Multiple Sclerosis (MS): The SURPASS Clinical Trial
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis (SURPASS):
ClinicalTrials.gov Description
===
Corporate press release
===
ClinicalTrials.gov Description
===
Corporate press release
===
Labels: clinical trial, elan, MS, multiple sclerosis, Tysabri
posted by Anthony Risser at 8:32 PM
0 Comments:
Post a Comment
<< Home